From First Unprovoked Seizure to Newly Diagnosed Epilepsy

Authors/Editors

Ettore Beghi
Peter Camfield
Dale Hesdorffer
Philippe Ryvlin

Publisher

John Libbey Eurotext

Additional Details

Length: 220 pp
Cost: 81 € (15% discount for ILAE members with code EPILEPSY)
Type: hardcover

Current knowledge on natural evolution of a first seizure, the role of co-morbid conditions, the impact of immediate versus delayed treatment and recent guidelines are thoroughly addressed. The new ideas and suggestions that emerge from this book offer challenging perspectives for both patient care and clinical as well as fundamental research.

The first section of the book includes an up to date review of epidemiological data, encompassing the natural evolution of single unprovoked seizures, risk factors for
recurrent seizures, and the potential for comorbid conditions such as depression, migraine, ADHD, and dysimmune metabolic disorders to promote the development of epilepsy. The impact of febrile convulsions on long-term brain hyperexcitability is also discussed.

The second section concentrates on therapeutic issues, concerning the management of single unprovoked seizures and newly diagnosed epilepsy. These include the impact of immediate versus deferred treatment and the choice of the most appropriate antiepileptic drug therapy.

Several methodological issues are addressed in parallel with the chapters, providing new insights into domains, such as the representativeness of the patient population in the studies under consideration, as well as the limitations and pitfalls of most randomised controlled trials. The value of these trials in the development of treatment guidelines is also discussed.

ISBN: 978-2-7420-0656-4

Purchase

Views: 146 Last Updated: June 14, 2018